Accudial Pharmaceutical Inc. has acquired Stephen Key Design, a licensing company specializing in rotating label technology.


AccuDial Pharmaceutical, Stephen Key Design, Spinformation, rotating label technology, Extended Content Rotating Labels, ECRL, Robert Terwilliger, Stephen Key, Spinformation label, label technology, weight-based dosing, Children's Accudial Acetaminophen for Pain & Fever












































































































































































































































INSIDE THIS ISSUE
News
Opinion
Other Services
Reprints / E-Prints
Submit News
White Papers

Supplier News Breaks Archives

AccuDial acquires Stephen Key Design

October 4th, 2011

PALM BEACH GARDENS, Fla. – Accudial Pharmaceutical Inc. has acquired Stephen Key Design, a licensing company specializing in rotating label technology.

The deal brings AccuDial Stephen Key Design's Spinformation rotating label system and expands Accudial's patent portfolio to over 50 patents for weight-based dosing and other Extended Content Rotating Labels (ECRL), which adds 75% more labeling space to a container.

"Stephen Key founded the company in 1998 and is a recognized leader in the $63 billion label industry. He will remain at the helm of Stephen Key Design LLC and continue as a member of Accudial's board of directors," stated Robert Terwilliger, chairman and chief executive officer of Accudial Pharmaceutical.

"In the past 13 years, hundreds of millions of Spinformation labels have been used on a
wide range of products," commented Stephen Key. "Spinformation labels have been used on Rexall Sundown Vitamins, Children's Accudial pediatric liquid medicines and Kirkwood Brand products, to name just a few. Spinformation has partnerships with a number of packaging industry leaders."

Plans call for Stephen Key to focus with Accudial on pharmaceutical applications for prescription, over-the-counter, nutritional supplements, injectable vials and vitamins. In addition, Stephen Key will work with Spinformation partners in the beverage, fruit drink, food industry and other commercial applications.

Accudial added that besides weight-based dosing, its ECRL can be used for product launches to notify consumers about a new or improved product; discount coupons on the inner label; Quick Reader (QR) codes that can lead consumers to a company's social media profiles; easy-to-read test using large fonts; multiple languages on the inner label to provide directions for multiple markets; illustrations, such as barrier grid animation, to depict conditions such as a throbbing pain in the shoulder or lower back; and daily dose and progress tracking for medicine taken multiple times per day.

Starting Oct. 17, Children's Accudial Acetaminophen for Pain & Fever with weight
based dosing will be available at Amazon.com and a number of leading online drug store
sites, according to Accudial. Children's Accudial Acetaminophen for Pain & Fever will be available in five flavors: cherry, dye-free cherry, bubblegum, strawberry and grape for children weighing 12 pounds to 95 pounds.

Advertisement